Cecilia Tecuapetla-Zavala

Mexico City, DIF 14269, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.

Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.

Journal: Pharmaceutics

Published: October 30, 2025

An Evaluation of Cation-Chloride Cotransporters NKCC1 and KCC2 in Carbamazepine-Resistant Rats.

An Evaluation of Cation-Chloride Cotransporters NKCC1 and KCC2 in Carbamazepine-Resistant Rats.

Journal: International journal of molecular sciences

Published: April 04, 2025

Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy.

Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy.

Journal: Pharmaceutics

Published: December 24, 2024

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.

Journal: International journal of molecular sciences

Published: October 29, 2022

Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling.

Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling.

Journal: Brain sciences

Published: April 13, 2022

Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Journal: International journal of molecular sciences

Published: October 12, 2020

Activation of adenosine receptors modulates the efflux transporters in brain capillaries and restores the anticonvulsant effect of carbamazepine in carbamazepine resistant rats developed by window-pentylenetetrazole kindling.

Activation of adenosine receptors modulates the efflux transporters in brain capillaries and restores the anticonvulsant effect of carbamazepine in carbamazepine resistant rats developed by window-pentylenetetrazole kindling.

Journal: Brain research

Published: April 05, 2019

Status epilepticus: Using antioxidant agents as alternative therapies.

Status epilepticus: Using antioxidant agents as alternative therapies.

Journal: Experimental and therapeutic medicine

Published: October 23, 2015

Overview of Nrf2 as Therapeutic Target in Epilepsy.

Overview of Nrf2 as Therapeutic Target in Epilepsy.

Journal: International journal of molecular sciences

Published: June 16, 2015

GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors.

GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors.

Journal: Frontiers in cellular neuroscience

Published: October 18, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026